Transgenomic's Q4 Revenues Slide 22 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Transgenomic reported after the close of the market on Thursday a 22 percent drop year over year in fourth quarter revenues.

For the three months ended Dec. 31, 2010, the Omaha, Neb.-based firm reported revenues of $5.1 million, compared to $6.5 million a year ago. In a statement, the firm said that fourth-quarter 2009 figures included an "exceptionally large" order of Wave instruments for the detection of genetic variation.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.

Mar
02
Sponsored by
VelaDx

This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV.